By Dominic Tyer (European Pharmaceutical Review)2025-09-30T09:23:02
The planned succession will also see him become Chair of the German pharma company’s Executive Board in May 2026.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:47:00
Sponsored by CPhI
2026-05-27T13:00:00 2026-05-27T14:00:00
Sponsored by TA Instruments
Site powered by Webvision Cloud